Stikeman Elliott and Skadden are advising CI, while Blake, Cassels & Graydon and Latham & Watkins are advising Mubadala Capital on the deal. CI Financial Corp....
You must be a Standard 1 Year member to access this content.
Skadden and Ice Miller advised Playa Bowls on the transaction, while Kirkland & Ellis served as legal counsel to Sycamore Partners. Sycamore Partners, a private equity...
You must be a Standard 1 Year member to access this content.
Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
You must be a Standard 1 Year member to access this content.
Skadden served as legal advisor to OceanSound Partners and its portfolio company, Gannett Fleming, on the deal. Gannett Fleming, a portfolio company of OceanSound Partners (“OceanSound”)...
You must be a Standard 1 Year member to access this content.
Skadden is advising Altice on the sale, while Meitar Law Offices and Bryan Cave Leighton Paisner are acting as legal advisors to Outbrain. Cravath is representing...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis is advising R1 RCM, Skadden is advising a special committee of the R1 RCM Inc. in the transaction, while Wachtell, Lipton, Rosen &...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher acted as PharmaCord’s legal counsel, while Skadden, Arps, Slate, Meagher & Flom LLP acted as Permira’s legal counsel on the deal. Permira,...
You must be a Standard 1 Year member to access this content.
Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
You must be a Standard 1 Year member to access this content.
Skadden and Elvinger Hoss Prussen represented Intelsat in the transaction, and Gibson, Dunn & Crutcher and Hogan Lovells represented SES. Debevoise & Plimpton advised Guggenheim Securities...
You must be a Standard 1 Year member to access this content.
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
You must be a Standard 1 Year member to access this content.
Skadden advised MorphoSys AG in the deal. MorphoSys AG has entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG (hereinafter collectively referred...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Kromann Reumert are advising Novo Holdings on the transaction, Skadden, Arps, Slate, Meagher & Flom is advising Catalent, Inc. and Jones Day is...
You must be a Standard 1 Year member to access this content.
